Lai-Ming Ching

478 total citations
17 papers, 410 citations indexed

About

Lai-Ming Ching is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lai-Ming Ching has authored 17 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Lai-Ming Ching's work include Immune Cell Function and Interaction (3 papers), Cancer therapeutics and mechanisms (3 papers) and Immunotherapy and Immune Responses (3 papers). Lai-Ming Ching is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer therapeutics and mechanisms (3 papers) and Immunotherapy and Immune Responses (3 papers). Lai-Ming Ching collaborates with scholars based in New Zealand, Canada and France. Lai-Ming Ching's co-authors include Baguley Bc, Wayne R. Joseph, Bruce C. Baguley, Kathryn E. Crosier, R. G. Miller, Heinrich Körner, Jonathon D. Sedgwick, Donald P. Goldsmith, Elaine S. Marshall and Kathleen G. Mountjoy and has published in prestigious journals such as Nature, The Journal of Immunology and Cancer Research.

In The Last Decade

Lai-Ming Ching

17 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lai-Ming Ching New Zealand	12	207	146	108	103	46	17	410
C. Brindley United Kingdom	11	322 1.6×	79 0.5×	65 0.6×	150 1.5×	22 0.5×	14	523
Steffanie L. Furtek United States	4	239 1.2×	256 1.8×	105 1.0×	97 0.9×	37 0.8×	4	480
Sueo Mukumoto Japan	8	310 1.5×	120 0.8×	54 0.5×	103 1.0×	26 0.6×	9	495
Teresa Carrascal Spain	9	332 1.6×	190 1.3×	66 0.6×	223 2.2×	29 0.6×	9	587
Zhuoxin Cheng China	14	280 1.4×	156 1.1×	159 1.5×	104 1.0×	41 0.9×	20	557
Young-Soon Na South Korea	12	271 1.3×	179 1.2×	70 0.6×	39 0.4×	25 0.5×	18	461
Lina Quan China	14	251 1.2×	216 1.5×	102 0.9×	171 1.7×	22 0.5×	27	558
Jean-Pierre Bizzari France	14	288 1.4×	267 1.8×	51 0.5×	58 0.6×	20 0.4×	24	515
Mark Edelstein United States	9	147 0.7×	88 0.6×	55 0.5×	42 0.4×	55 1.2×	27	321
Per Olov Gunnarsson Sweden	13	140 0.7×	152 1.0×	59 0.5×	69 0.7×	13 0.3×	33	529

Countries citing papers authored by Lai-Ming Ching

Since Specialization

Citations

This map shows the geographic impact of Lai-Ming Ching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai-Ming Ching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai-Ming Ching more than expected).

Fields of papers citing papers by Lai-Ming Ching

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lai-Ming Ching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai-Ming Ching. The network helps show where Lai-Ming Ching may publish in the future.

Co-authorship network of co-authors of Lai-Ming Ching

This figure shows the co-authorship network connecting the top 25 collaborators of Lai-Ming Ching. A scholar is included among the top collaborators of Lai-Ming Ching based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lai-Ming Ching. Lai-Ming Ching is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ching, Lai-Ming, Brian D. Palmer, Petr Tomek, Jack U. Flanagan, & Kimiora Henare. (2015). Abstract 4469: A novel class of inhibitors of the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1) with potential for the treatment of cancer. Cancer Research. 75(15_Supplement). 4469–4469. 1 indexed citations

Woon, See‐Tarn, Sandy Hung, R. M. Sutherland, et al.. (2007). NF-kappaB-independent induction of endothelial cell apoptosis by the vascular disrupting agent DMXAA.. PubMed. 27(1A). 327–34. 11 indexed citations

Wang, Liang‐Chuan S., See‐Tarn Woon, Bruce C. Baguley, & Lai-Ming Ching. (2006). Inhibition of DMXAA-Induced Tumor Necrosis Factor Production in Murine Splenocyte Cultures by NF-κB Inhibitors. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 16(1). 1–14. 12 indexed citations

Woon, See‐Tarn, et al.. (2005). A Comparison of the Ability of DMXAA and Xanthenone Analogues to Activate NF-κB in Murine and Human Cell Lines. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 15(7). 351–364. 13 indexed citations

Lu, Jun, Brian D. Palmer, P. Kestell, et al.. (2003). Thalidomide metabolites in mice and patients with multiple myeloma.. PubMed. 9(5). 1680–8. 32 indexed citations

Chung, Francisco, Brian D. Palmer, George W. Muller, et al.. (2003). Effect of 3-Fluorothalidomide and 3-Methylthalidomide Enantiomers on Tumor Necrosis Factor Production and Antitumor Responses to the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid (DMXAA). Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 14(2). 75–82. 13 indexed citations

Woon, See‐Tarn, Bruce C. Baguley, Brian D. Palmer, John D. Fraser, & Lai-Ming Ching. (2002). Uptake of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and activation of NF-kappaB in human tumor cell lines.. PubMed. 13(2). 95–101. 11 indexed citations

Kestell, P., et al.. (2001). Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Cancer Chemotherapy and Pharmacology. 47(6). 491–497. 17 indexed citations

Ching, Lai-Ming, Donald P. Goldsmith, Wayne R. Joseph, et al.. (1999). Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice.. PubMed. 59(14). 3304–7. 81 indexed citations

10.

Joseph, Wayne R., et al.. (1999). Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.. PubMed. 59(3). 633–8. 71 indexed citations

11.

Ching, Lai-Ming, Wayne R. Joseph, Kathryn E. Crosier, & Baguley Bc. (1994). Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).. PubMed. 54(4). 870–2. 69 indexed citations

12.

Baguley, Bruce C., Graeme J. Finlay, & Lai-Ming Ching. (1992). Resistance mechanisms to topoisomerase poisons: the application of cell culture methods.. PubMed. 4(7). 267–74. 12 indexed citations

13.

Ching, Lai-Ming & Bruce C. Baguley. (1989). Effect of flavone acetic acid (NSC 347 512) on splenic cytotoxic effector cells and their role in tumour necrosis. European Journal of Cancer and Clinical Oncology. 25(5). 821–828. 20 indexed citations

14.

Ching, Lai-Ming & R. G. Miller. (1982). Development of cytotoxic T lymphocyte precursor cells in T cell colonies grown in vitro.. The Journal of Immunology. 129(6). 2345–2351. 7 indexed citations

15.

Ching, Lai-Ming & Richard G. Miller. (1981). Generation of cytotoxic T-lymphocyte precursor cells in T-cell colonies grown in vitro. Nature. 289(5800). 802–804. 11 indexed citations

16.

Ching, Lai-Ming, S. Muraoka, & R. G. Miller. (1981). Differentiation of T cells from immature precursors in murine T cell colonies.. The Journal of Immunology. 127(5). 2156–2163. 14 indexed citations

17.

Ching, Lai-Ming & R. G. Miller. (1980). Characterization of in vitro T lymphocyte colonies from normal mouse spleen cells: colonies containing cytotoxic lymphocyte precursors.. The Journal of Immunology. 124(2). 696–701. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact